Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis.
about
Epicardial fat tissue in patients with psoriasis:a systematic review and meta-analysisAtherosclerosis in psoriatic disease: latest evidence and clinical implicationsMaking the next steps in psoriatic arthritis management: current status and future directionsRelationships between Adipose Tissue and Psoriasis, with or without ArthritisUpdates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms.No association between psoriasis and diabetes in the U.S. population.Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials.Biomarkers to Diagnose Early Arthritis in Patients With Psoriasis.Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasisPsoriatic arthritis and sacroiliitis are associated with increased vascular inflammation by 18-fluorodeoxyglucose positron emission tomography computed tomography: baseline report from the Psoriasis Atherosclerosis and Cardiometabolic Disease InitiaCardiovascular risk in psoriatic arthritis - a cross-sectional study.Qualifying unmet needs and improving standards of care in psoriatic arthritis.Cardiovascular risk in patients with psoriatic arthritis.Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis.Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture.Association of ustekinumab and briakinumab with major adverse cardiovascular events: An appraisal of meta-analyses and industry sponsored pooled analyses to datePsoriasis and new-onset diabetes: a Danish nationwide cohort studyThe impact of identifying carotid plaque on addressing cardiovascular risk in psoriatic arthritis.Psoriatic Arthritis and Burden of Disease: Patient Perspectives from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force.Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritisBurden of disease: psoriasis and psoriatic arthritis.Diagnosing and treating psoriatic arthritis: an update.Cardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database.Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink.Diabetes mellitus and arthritis: is it a risk factor or comorbidity?: A systematic review and meta-analysis.Cardiometabolic Disorders in Psoriatic Disease.Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis.Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry.Prevalence of psoriatic arthritis and its correlates among patients with psoriasis in Greece: results from a large retrospective study.Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics.Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis.Ustekinumab Treatment and Improvement of Physical Function and Health-Related Quality of Life in Patients With Psoriatic ArthritisCross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis.Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity.Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease.Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis.Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: a nation-wide study.Epidemiology of mental health comorbidity in psoriasis.Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.
P2860
Q26744434-3C84964C-1BBC-4FCE-9858-D1EC09F81A78Q26783501-BF49E38A-B38D-4312-93B0-6299F34262AFQ26783506-8D29C425-1EB2-4747-8436-CC08D92E4573Q27025534-B5C2095E-EF1D-43D6-898A-B0A26FA7EB79Q30250110-C8AA6E60-67A8-4344-8C87-8CA6178B425FQ33796202-034C3A00-2384-4CD6-B7EC-E8DA45DC203BQ34189897-6A1EAEAC-69C5-4095-A8FA-445E86C2B230Q34563661-BF29C0A7-E74E-4760-BE69-66EF9B3AEC25Q34643790-AE137163-4E00-4825-A60D-53BD3480D62CQ34668556-EDA8AC9B-D999-4A53-8D68-AC780B3B1806Q34717077-F91FCDCC-6764-4556-B3B6-621EFE07C991Q34803582-78227718-5942-416E-BEDB-D0664855C7ABQ35974962-A9D96743-695C-48E0-B478-4CD2F78EBE95Q36052215-935BC355-2AF1-47DE-A324-91DED29F20E3Q36369917-535F1FBB-EEAC-4583-9DC0-C948B3FEBE16Q36643600-39C39E3B-F750-4B1E-9A3F-140497A4AED8Q37022693-3446B838-338F-4994-B9CF-0798946163A7Q37144730-8B2209FF-4424-406B-AFF2-3B054869DD3FQ37208460-FF034BCA-DE9A-46AE-8DC8-E23F93838BFFQ37465518-891C05B1-6C05-462E-A720-8C479E6A4964Q37672346-D5639AD0-5D97-46F6-997B-38FAD4A337C2Q38114850-837650CD-4D79-494C-BA5F-A3FD132D0D9AQ38165235-AF1DDC8F-F081-4A9C-BDC8-3C8FE24024FFQ38653041-3454F1B0-81FD-4C3E-A138-4EBF4FA0EFA4Q39106788-F25FEA25-11A0-4640-8A21-D564E7291F79Q39283765-C664B6CB-4853-4C44-AAB7-2284B05A73ACQ40069191-D1AC6DCA-6372-4417-9A0A-6571BABBAB04Q40081220-6613C729-9029-4304-AE15-956C307CDE3BQ40311189-E5271031-57CD-4908-BADF-2F08F332B253Q40533508-B61F1174-66BB-4D18-8DD2-78FEC15ABD0AQ41060904-C876D730-7375-4EEA-88D7-EDAC68C21845Q41588352-36E05290-27C6-40ED-838B-CD8FF6B9415AQ41813468-781A8D70-3162-457D-8F18-2D9B768A981EQ42275944-827E159C-677E-4D31-9333-F7A3BBB15A27Q43472253-B3853381-141B-42A0-B19B-AB14CB4E3438Q44204800-58E38EC9-3F85-465A-96CD-1CFF3DA75116Q44270837-C1C8BAB8-0AEC-4AD2-99B4-7AFC767FE526Q44289756-D09AEBDF-1939-4E1E-AAB7-3E73BB254A98Q45983342-A008068C-58CB-4244-AAA2-2CA126759315Q46337002-2F5B90DE-731C-4FB2-9E68-C518491099E2
P2860
Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Cardiovascular and other comor ...... with patients with psoriasis.
@en
Cardiovascular and other comor ...... with patients with psoriasis.
@nl
type
label
Cardiovascular and other comor ...... with patients with psoriasis.
@en
Cardiovascular and other comor ...... with patients with psoriasis.
@nl
prefLabel
Cardiovascular and other comor ...... with patients with psoriasis.
@en
Cardiovascular and other comor ...... with patients with psoriasis.
@nl
P2093
P2860
P356
P1476
Cardiovascular and other comor ...... with patients with psoriasis.
@en
P2093
Arane Thavaneswaran
Cheryl F Rosen
Janice A Husted
Richard J Cook
Vinod Chandran
P2860
P304
P356
10.1002/ACR.20627
P577
2011-12-01T00:00:00Z